| 35.09 -0.24 (-0.68%) | 12-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 42.21 | 1-year : | 49.3 |
| Resists | First : | 36.13 | Second : | 42.21 |
| Pivot price | 34.69  |
|||
| Supports | First : | 32.43 | Second : | 30.14 |
| MAs | MA(5) : | 35.01  |
MA(20) : | 34.08 |
| MA(100) : | 29.13 |
MA(250) : | 0 | |
| MACD | MACD : | 1.1 |
Signal : | 1.2 |
| %K %D | K(14,3) : | 70.3 |
D(3) : | 69.4 |
| RSI | RSI(14): 65.7 |
|||
| 52-week | High : | 36.13 | Low : | 20.09 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CANC ] has closed below upper band by 37.8%. Bollinger Bands are 33.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.74 - 35.94 | 35.94 - 36.13 |
| Low: | 34.39 - 34.61 | 34.61 - 34.81 |
| Close: | 34.77 - 35.13 | 35.13 - 35.45 |
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Thu, 04 Dec 2025
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - Business Insider
Wed, 03 Dec 2025
Discipline and Rules-Based Execution in CANC Response - news.stocktradersdaily.com
Tue, 02 Dec 2025
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - Yahoo Finance
Wed, 26 Nov 2025
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Sat, 22 Nov 2025
Behavioral Patterns of CANC and Institutional Flows - news.stocktradersdaily.com
Tue, 11 Nov 2025
(CANC) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|